Back to results
US 10,869,869 B2Granted
Method of adjuvant cancer treatment
AssigneeNovartis AG
InventorsSylvie Laquerre, Peter F. Lebowitz
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of providing adjuvant treatment to a human patient which comprises administering to such a patient therapeutically effective doses of dabrafenib and trametinib for a time period sufficient to increase relapse-free survival (RFS).
Claims3
A method for providing adjuvant treatment to a patient with a prior diagnosis of melanoma which has been resected, comprising the steps of:
- a) administering to said patient therapeutically effective doses of dabrafenib and trametinib, wherein said dabrafenib is administered at an amount of 150 mg twice a day and said trametinib is administered at an amount of 2 mg once daily;
- and
- b) increasing relapse-free (RFS) of said patient after resection of said melanoma.
Dependencies are inferred from the claim text.